R&D progress News

GSK Reports a 2% Increase in Q1 Sales to £7.5 Billion, Highlighting Strong Portfolio Performance

GSK plc announced a 2% increase in Q1 2023 sales to £6.95 billion, with a 55% surge in EPS and a 49% rise in operating profit. CEO Emma Walmsley emphasized the company's strong por...

GSK Reports a 2% Increase in Q1 Sales to £7.5 Billion, Highlighting Strong Portfolio Performance

GSK plc reports a 2% increase in Q1 2023 sales to £6.95 billion, with a 55% surge in EPS and a 49% increase in operating profit. CEO Emma Walmsley emphasizes the company's strong p...